Medicure (MCUJF) Asset Writedowns and Impairment (2009 - 2020)
Medicure's (MCUJF) quarterly Asset Writedowns and Impairment came in at $284577.3 in Q4 2020, down 93.46% year-on-year from $4.4 million in Q1 2020, and up 279.41% quarter-over-quarter from $75005.2 in Q2 2020.
Medicure (MCUJF) Asset Writedowns and Impairment (2009 - 2020) Analysis & Trends
Medicure's Asset Writedowns and Impairment history runs 9 years deep, the most recent figure standing at $284577.3 for Q4 2020.
- On a quarterly basis, Asset Writedowns and Impairment fell 93.46% year-over-year to $284577.3 in Q4 2020; TTM through Dec 2020 was $513982.7, a 88.26% decrease from a year earlier, with the FY2023 full-year figure at $205303.1, up 602.41% from the prior year.
- Asset Writedowns and Impairment climbed to $284577.3 in Q4 2020 per MCUJF's latest filing, from $75005.2 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $4.4 million in Q4 2019 and bottomed at $75005.2 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 284,577.28 |
| Dec 31, 2020 | 284,577.28 |
| Jun 30, 2020 | 75,005.21 |
| Jun 30, 2020 | 75,005.21 |
| Mar 31, 2020 | 154,400.18 |
| Mar 31, 2020 | 154,400.18 |
| Dec 31, 2019 | 4.35 Mn |
| Dec 31, 2019 | 4.35 Mn |
| Dec 31, 2015 | -884,538.00 |
| Dec 31, 2015 | -884,538.00 |
| Sep 30, 2015 | 5,493.69 |
| Sep 30, 2015 | 5,493.69 |
| Aug 31, 2014 | 20,518.62 |
| Aug 31, 2014 | 20,518.62 |
| May 31, 2013 | 13,198.78 |
| May 31, 2013 | 13,198.78 |
| Aug 31, 2012 | 6,094.88 |
| Aug 31, 2012 | 6,094.88 |
| May 31, 2012 | -106,390.08 |
| May 31, 2012 | -106,390.08 |